| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0000082 | G1/s transition of mitotic cell cycle | Increases phenotype | PMID:30684532 |
| GO:0000084 | Mitotic s phase | Increases phenotype | PMID:30684532; PMID:31601247; PMID:38211720 |
| GO:0000086 | G2/m transition of mitotic cell cycle | Affects phenotype | PMID:31601247 |
| GO:0000165 | Mapk cascade | Affects phenotype | PMID:24793377 |
| GO:0001541 | Ovarian follicle development | Decreases phenotype | PMID:30629253; PMID:31424294 |
| GO:0001547 | Antral ovarian follicle growth | Increases phenotype | PMID:31424294 |
| GO:0001552 | Ovarian follicle atresia | Increases phenotype | PMID:37002642 |
| GO:0001649 | Osteoblast differentiation | Decreases phenotype | PMID:34850234 |
| GO:0001692 | Histamine metabolic process | Affects phenotype | PMID:31778932 |
| GO:0001825 | Blastocyst formation | Decreases phenotype | PMID:33476676; PMID:37286763 |
| GO:0001890 | Placenta development | Affects phenotype | PMID:32071231 |
| GO:0001958 | Endochondral ossification | Decreases phenotype | PMID:34850234 |
| GO:0002062 | Chondrocyte differentiation | Decreases phenotype | PMID:34850234 |
| GO:0002156 | Negative regulation of thyroid hormone mediated signaling pathway | Increases phenotype | PMID:27213244 |
| GO:0002157 | Positive regulation of thyroid hormone mediated signaling pathway | Increases phenotype | PMID:29146198 |
| GO:0003006 | Developmental process involved in reproduction | Increases phenotype | PMID:30629253; PMID:31132128 |
| GO:0003300 | Cardiac muscle hypertrophy | Increases phenotype | PMID:37611474 |
| GO:0004000 | Adenosine deaminase activity | Increases phenotype | PMID:39577800 |
| GO:0004053 | Arginase activity | Increases phenotype | PMID:35900689 |
| GO:0004111 | Creatine kinase activity | Increases phenotype | PMID:35561261 |
| GO:0004112 | Cyclic-nucleotide phosphodiesterase activity | Increases phenotype | PMID:39577800 |
| GO:0004457 | Lactate dehydrogenase activity | Increases phenotype | PMID:35561261 |
| GO:0004602 | Glutathione peroxidase activity | Affects phenotype | PMID:32742594; PMID:34838688; PMID:35561261 |
| GO:0004784 | Superoxide dismutase activity | Decreases phenotype | PMID:32742594; PMID:33098627; PMID:39059691; PMID:39793866 |
| GO:0005245 | Voltage-gated calcium channel activity | Increases phenotype | PMID:35457000 |
| GO:0005911 | Cell-cell junction | Decreases phenotype | PMID:28808208 |
| GO:0005975 | Carbohydrate metabolic process | Affects phenotype | PMID:32203925 |
| GO:0006014 | D-ribose metabolic process | Affects phenotype | PMID:32071231 |
| GO:0006082 | Organic acid metabolic process | Affects phenotype | PMID:32203925 |
| GO:0006094 | Gluconeogenesis | Increases phenotype | PMID:31344369 |
| GO:0006096 | Glycolytic process | Affects phenotype | PMID:36011004 |
| GO:0006105 | Succinate metabolic process | Affects phenotype | PMID:31778932 |
| GO:0006171 | Camp biosynthetic process | Increases phenotype | PMID:28858478 |
| GO:0006306 | Dna methylation | Affects phenotype | PMID:31683443 |
| GO:0006338 | Chromatin remodeling | Increases phenotype | PMID:33916708 |
| GO:0006520 | Amino acid metabolic process | Affects phenotype | PMID:32203925 |
| GO:0006523 | Alanine biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0006537 | Glutamate biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0006545 | Glycine biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0006577 | Amino-acid betaine metabolic process | Affects phenotype | PMID:31778932 |
| GO:0006629 | Lipid metabolic process | Affects phenotype | PMID:31820560 |
| GO:0006631 | Fatty acid metabolic process | Affects phenotype | PMID:32071231; PMID:38908815 |
| GO:0006633 | Fatty acid biosynthetic process | Affects phenotype | PMID:30145421 |
| GO:0006641 | Triglyceride metabolic process | Affects phenotype | PMID:31683443; PMID:35561261 |
| GO:0006695 | Cholesterol biosynthetic process | Increases phenotype | PMID:30145421 |
| GO:0006701 | Progesterone biosynthetic process | Decreases phenotype | PMID:31424294 |
| GO:0006749 | Glutathione metabolic process | Affects phenotype | PMID:31778932; PMID:31875995; PMID:39736419 |
| GO:0006874 | Cellular calcium ion homeostasis | Affects phenotype | PMID:34748853 |
| GO:0006915 | Apoptotic process | Increases phenotype | PMID:33749030; PMID:38908815; PMID:39577800 |
| GO:0006974 | Cellular response to dna damage stimulus | Increases phenotype | PMID:31881267; PMID:32244372 |
| GO:0007005 | Mitochondrion organization | Decreases phenotype | PMID:37286763 |
| GO:0007056 | Spindle assembly involved in female meiosis | Decreases phenotype | PMID:33476676 |
| GO:0007281 | Germ cell development | Decreases phenotype | PMID:29741722; PMID:31532523 |
| GO:0007283 | Spermatogenesis | Decreases phenotype | PMID:29741722; PMID:29940534; PMID:31532523; PMID:33098627; PMID:34838688 |
| GO:0007565 | Female pregnancy | Decreases phenotype | PMID:30629253 |
| GO:0007566 | Embryo implantation | Affects phenotype | PMID:34831106 |
| GO:0007618 | Mating | Affects phenotype | PMID:30629253 |
| GO:0007631 | Feeding behavior | Increases phenotype | PMID:35561261 |
| GO:0008202 | Steroid metabolic process | Affects phenotype | PMID:24563381 |
| GO:0008206 | Bile acid metabolic process | Affects phenotype | PMID:39298647 |
| GO:0008210 | Estrogen metabolic process | Affects phenotype | PMID:33753083; PMID:37357847 |
| GO:0008234 | Cysteine-type peptidase activity | Increases phenotype | PMID:33312107 |
| GO:0008283 | Cell population proliferation | Increases phenotype | PMID:25111128; PMID:28616630; PMID:28808208; PMID:30684532; PMID:28808208; PMID:30684532; PMID:28916285; PMID:30352284; PMID:30684532; PMID:30822521; PMID:31945527; PMID:33605785; PMID:36011004; PMID:37224786; PMID:37234927; PMID:37675141; PMID:37834465; PMID:38185387; PMID:39577800 |
| GO:0008284 | Positive regulation of cell population proliferation | Increases phenotype | PMID:28591870; PMID:39032682; PMID:29146198; PMID:30099086; PMID:30196065; PMID:32023790; PMID:32105160; PMID:34270681; PMID:36565802; PMID:38657712 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:30196065; PMID:32023790; PMID:32105160; PMID:32763284; PMID:34831106 |
| GO:0008610 | Lipid biosynthetic process | Increases phenotype | PMID:27003841; PMID:27815650; PMID:30959087 |
| GO:0008652 | Amino acid biosynthetic process | Affects phenotype | PMID:31121516; PMID:31778932 |
| GO:0009094 | L-phenylalanine biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0009099 | Valine biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0009441 | Glycolate metabolic process | Affects phenotype | PMID:32071231 |
| GO:0010424 | Dna methylation on cytosine within a cg sequence | Affects phenotype | PMID:31601247 |
| GO:0010452 | Histone h3-k36 methylation | Decreases phenotype | PMID:37315367 |
| GO:0010460 | Positive regulation of heart rate | Increases phenotype | PMID:25723814 |
| GO:0010729 | Positive regulation of hydrogen peroxide biosynthetic process | Increases phenotype | PMID:35900689 |
| GO:0010759 | Positive regulation of macrophage chemotaxis | Increases phenotype | PMID:28903498 |
| GO:0010825 | Positive regulation of centrosome duplication | Increases phenotype | PMID:27998958 |
| GO:0010826 | Negative regulation of centrosome duplication | Decreases phenotype | PMID:27998958 |
| GO:0010867 | Positive regulation of triglyceride biosynthetic process | Increases phenotype | PMID:38588857 |
| GO:0010884 | Positive regulation of lipid storage | Increases phenotype | PMID:27273607 |
| GO:0010906 | Regulation of glucose metabolic process | Increases phenotype | PMID:37002642 |
| GO:0010942 | Positive regulation of cell death | Increases phenotype | PMID:30196065; PMID:32023790; PMID:34831106 |
| GO:0014808 | Release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | Increases phenotype | PMID:25723814 |
| GO:0015943 | Formate biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:25111128; PMID:31424294; PMID:33098627; PMID:34838688 |
| GO:0016049 | Cell growth | Decreases phenotype | PMID:30352284 |
| GO:0016477 | Cell migration | Increases phenotype | PMID:28808208; PMID:36011004; PMID:37234927 |
| GO:0016887 | Atp hydrolysis activity | Decreases phenotype | PMID:29079494 |
| GO:0018158 | Protein oxidation | Increases phenotype | PMID:29079494; PMID:31344369 |
| GO:0019369 | Arachidonic acid metabolic process | Affects phenotype | PMID:38908815 |
| GO:0019413 | Acetate biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0019432 | Triglyceride biosynthetic process | Increases phenotype | PMID:25111128; PMID:30145421; PMID:31344369 |
| GO:0019695 | Choline metabolic process | Affects phenotype | PMID:31778932 |
| GO:0022602 | Ovulation cycle process | Affects phenotype | PMID:30629253 |
| GO:0030182 | Neuron differentiation | Decreases phenotype | PMID:39577800 |
| GO:0030187 | Melatonin biosynthetic process | Affects phenotype | PMID:33098627 |
| GO:0030879 | Mammary gland development | Increases phenotype | PMID:30102602 |
| GO:0030954 | Astral microtubule nucleation | Increases phenotype | PMID:27998958 |
| GO:0031116 | Positive regulation of microtubule polymerization | Increases phenotype | PMID:27998958 |
| GO:0031324 | Negative regulation of cellular metabolic process | Increases phenotype | PMID:34174261 |
| GO:0032024 | Positive regulation of insulin secretion | Increases phenotype | PMID:37002642 |
| GO:0032776 | Dna methylation on cytosine | Increases phenotype | PMID:30196065 |
| GO:0032869 | Cellular response to insulin stimulus | Affects phenotype | PMID:34186270 |
| GO:0032929 | Negative regulation of superoxide anion generation | Increases phenotype | PMID:37002642 |
| GO:0033148 | Positive regulation of intracellular estrogen receptor signaling pathway | Increases phenotype | PMID:25371027; PMID:27213244; PMID:27473340; PMID:31388671; PMID:34831106 |
| GO:0033601 | Positive regulation of mammary gland epithelial cell proliferation | Increases phenotype | PMID:29526645 |
| GO:0033685 | Negative regulation of luteinizing hormone secretion | Increases phenotype | PMID:37002642 |
| GO:0034440 | Lipid oxidation | Increases phenotype | PMID:29199064; PMID:29940534; PMID:39577800; PMID:39793866 |
| GO:0034454 | Microtubule anchoring at centrosome | Increases phenotype | PMID:27998958 |
| GO:0035148 | Tube formation | Affects phenotype | PMID:30352284 |
| GO:0035264 | Multicellular organism growth | Decreases phenotype | PMID:36310694 |
| GO:0035794 | Positive regulation of mitochondrial membrane permeability | Increases phenotype | PMID:30196065 |
| GO:0035847 | Uterine epithelium development | Increases phenotype | PMID:27473340 |
| GO:0035936 | Testosterone secretion | Decreases phenotype | PMID:31532523; PMID:37357847 |
| GO:0035938 | Estradiol secretion | Increases phenotype | PMID:30817981; PMID:31132128; PMID:31532523; PMID:32155818 |
| GO:0036343 | Psychomotor behavior | Affects phenotype | PMID:39577800 |
| GO:0036440 | Citrate synthase activity | Decreases phenotype | PMID:31344369 |
| GO:0040016 | Embryonic cleavage | Decreases phenotype | PMID:33476676; PMID:37286763 |
| GO:0040029 | Epigenetic regulation of gene expression | Affects phenotype | PMID:31532523; PMID:31683443; PMID:38338858 |
| GO:0042126 | Nitrate metabolic process | Affects phenotype | PMID:37002642; PMID:39793866 |
| GO:0042127 | Regulation of cell population proliferation | Increases phenotype | PMID:30196065 |
| GO:0042214 | Terpene metabolic process | Affects phenotype | PMID:38908815 |
| GO:0042310 | Vasoconstriction | Increases phenotype | PMID:36310694 |
| GO:0042311 | Vasodilation | Increases phenotype | PMID:36310694 |
| GO:0042417 | Dopamine metabolic process | Affects phenotype | PMID:32071231 |
| GO:0042428 | Serotonin metabolic process | Affects phenotype | PMID:32071231 |
| GO:0042448 | Progesterone metabolic process | Affects phenotype | PMID:37357847 |
| GO:0042701 | Progesterone secretion | Decreases phenotype | PMID:32155818; PMID:37182577 |
| GO:0042755 | Eating behavior | Increases phenotype | PMID:29909315 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:29741722; PMID:38134982 |
| GO:0043066 | Negative regulation of apoptotic process | Increases phenotype | PMID:38657712 |
| GO:0043396 | Corticotropin-releasing hormone secretion | Decreases phenotype | PMID:30940137 |
| GO:0043627 | Response to estrogen | Affects phenotype | PMID:31201878 |
| GO:0044030 | Regulation of dna methylation | Affects phenotype | PMID:38338858 |
| GO:0044237 | Cellular metabolic process | Affects phenotype | PMID:31601247; PMID:31601247; PMID:33181973; PMID:37315367; PMID:31812737; PMID:32244372; PMID:33181973; PMID:33749030; PMID:33749030; PMID:34748853; PMID:34474090; PMID:34838688; PMID:35405288; PMID:35457000; PMID:35561261; PMID:36674557; PMID:37224786; PMID:37234927; PMID:37315367; PMID:37357847; PMID:39736419; PMID:39793866 |
| GO:0044319 | Wound healing, spreading of cells | Increases phenotype | PMID:30292839; PMID:31601247; PMID:35405288; PMID:37234927 |
| GO:0044849 | Estrous cycle | Affects phenotype | PMID:31132128 |
| GO:0045019 | Negative regulation of nitric oxide biosynthetic process | Increases phenotype | PMID:35900689 |
| GO:0045023 | G0 to g1 transition | Affects phenotype | PMID:38211720 |
| GO:0045333 | Cellular respiration | Decreases phenotype | PMID:37657410 |
| GO:0045429 | Positive regulation of nitric oxide biosynthetic process | Increases phenotype | PMID:38369087 |
| GO:0045444 | Fat cell differentiation | Affects phenotype | PMID:34186270 |
| GO:0045542 | Positive regulation of cholesterol biosynthetic process | Increases phenotype | PMID:38588857 |
| GO:0045600 | Positive regulation of fat cell differentiation | Increases phenotype | PMID:27273607 |
| GO:0045624 | Positive regulation of t-helper cell differentiation | Increases phenotype | PMID:32911021 |
| GO:0045661 | Regulation of myoblast differentiation | Affects phenotype | PMID:32750123 |
| GO:0045786 | Negative regulation of cell cycle | Increases phenotype | PMID:38301581 |
| GO:0045930 | Negative regulation of mitotic cell cycle | Increases phenotype | PMID:32023790 |
| GO:0045931 | Positive regulation of mitotic cell cycle | Increases phenotype | PMID:32023790 |
| GO:0046034 | Atp metabolic process | Affects phenotype | PMID:31778932 |
| GO:0046085 | Adenosine metabolic process | Affects phenotype | PMID:31778932 |
| GO:0046102 | Inosine metabolic process | Affects phenotype | PMID:31778932 |
| GO:0046209 | Nitric oxide metabolic process | Affects phenotype | PMID:39577800; PMID:39793866 |
| GO:0046621 | Negative regulation of organ growth | Increases phenotype | PMID:31201878 |
| GO:0046622 | Positive regulation of organ growth | Increases phenotype | PMID:27473340 |
| GO:0046882 | Negative regulation of follicle-stimulating hormone secretion | Increases phenotype | PMID:37002642 |
| GO:0048143 | Astrocyte activation | Increases phenotype | PMID:39577800 |
| GO:0048484 | Enteric nervous system development | Affects phenotype | PMID:36615857 |
| GO:0048699 | Generation of neurons | Affects phenotype | PMID:36615857 |
| GO:0048863 | Stem cell differentiation | Increases phenotype | PMID:36565802 |
| GO:0048874 | Host-mediated regulation of intestinal microbiota composition | Affects phenotype | PMID:33078840 |
| GO:0050665 | Hydrogen peroxide biosynthetic process | Increases phenotype | PMID:31344369 |
| GO:0050996 | Positive regulation of lipid catabolic process | Increases phenotype | PMID:35900689; PMID:37002642 |
| GO:0051229 | Meiotic spindle disassembly | Increases phenotype | PMID:31881267 |
| GO:0051310 | Metaphase plate congression | Decreases phenotype | PMID:33476676 |
| GO:0051463 | Negative regulation of cortisol secretion | Increases phenotype | PMID:38966215 |
| GO:0051726 | Regulation of cell cycle | Increases phenotype | PMID:31750923 |
| GO:0051881 | Regulation of mitochondrial membrane potential | Increases phenotype | PMID:33749030; PMID:37834465; PMID:39793866; PMID:39929295 |
| GO:0051882 | Mitochondrial depolarization | Decreases phenotype | PMID:39793866 |
| GO:0051899 | Membrane depolarization | Affects phenotype | PMID:39929295 |
| GO:0052697 | Xenobiotic glucuronidation | Increases phenotype | PMID:27213244 |
| GO:0055074 | Calcium ion homeostasis | Affects phenotype | PMID:28858478; PMID:35561261 |
| GO:0060137 | Maternal process involved in parturition | Decreases phenotype | PMID:30629253 |
| GO:0060180 | Female mating behavior | Affects phenotype | PMID:31132128 |
| GO:0060326 | Cell chemotaxis | Affects phenotype | PMID:35405288; PMID:37224786; PMID:38185387 |
| GO:0060548 | Negative regulation of cell death | Increases phenotype | PMID:37487893 |
| GO:0060603 | Mammary gland duct morphogenesis | Increases phenotype | PMID:31201878 |
| GO:0060648 | Mammary gland bud morphogenesis | Increases phenotype | PMID:29526645 |
| GO:0060763 | Mammary duct terminal end bud growth | Increases phenotype | PMID:29526645 |
| GO:0061370 | Testosterone biosynthetic process | Increases phenotype | PMID:28482050; PMID:31424294; PMID:33098627; PMID:33753083; PMID:37357847 |
| GO:0061548 | Ganglion development | Affects phenotype | PMID:36982030 |
| GO:0070050 | Neuron cellular homeostasis | Affects phenotype | PMID:39000048 |
| GO:0070059 | Intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | Increases phenotype | PMID:35940389 |
| GO:0070091 | Glucagon secretion | Decreases phenotype | PMID:36674557 |
| GO:0070192 | Chromosome organization involved in meiotic cell cycle | Affects phenotype | PMID:31881267 |
| GO:0070734 | Histone h3-k27 methylation | Increases phenotype | PMID:31881267 |
| GO:0070994 | Detection of oxidative stress | Affects phenotype | PMID:32742594; PMID:35561261; PMID:37286763 |
| GO:0071466 | Cellular response to xenobiotic stimulus | Affects phenotype | PMID:30145421 |
| GO:0071557 | Histone h3-k27 demethylation | Affects phenotype | PMID:33476676 |
| GO:0072593 | Reactive oxygen species metabolic process | Increases phenotype | PMID:32023790; PMID:34748853; PMID:38211720; PMID:37357847; PMID:38211720; PMID:39736419; PMID:39793866 |
| GO:0086003 | Cardiac muscle cell contraction | Increases phenotype | PMID:25723814 |
| GO:0090116 | C-5 methylation of cytosine | Affects phenotype | PMID:31881267; PMID:32105160 |
| GO:0090303 | Positive regulation of wound healing | Increases phenotype | PMID:39032682 |
| GO:0090598 | Male anatomical structure morphogenesis | Affects phenotype | PMID:31201878 |
| GO:0097621 | Monoamine oxidase activity | Increases phenotype | PMID:39577800 |
| GO:0097676 | Histone h3-k36 dimethylation | Decreases phenotype | PMID:37315367 |
| GO:0097722 | Sperm motility | Decreases phenotype | PMID:33098627; PMID:34838688 |
| GO:0098708 | Glucose import across plasma membrane | Increases phenotype | PMID:25111128 |
| GO:0110053 | Regulation of actin filament organization | Affects phenotype | PMID:31750923 |
| GO:0140042 | Lipid droplet formation | Increases phenotype | PMID:32220626; PMID:33865937; PMID:35561261; PMID:35736896 |
| GO:0140253 | Cell-cell fusion | Increases phenotype | PMID:33605785 |
| GO:1900110 | Negative regulation of histone h3-k9 dimethylation | Increases phenotype | PMID:31532523 |
| GO:1900113 | Negative regulation of histone h3-k9 trimethylation | Increases phenotype | PMID:31532523 |
| GO:1900194 | Negative regulation of oocyte maturation | Increases phenotype | PMID:33476676 |
| GO:1900825 | Regulation of membrane depolarization during cardiac muscle cell action potential | Affects phenotype | PMID:38310357 |
| GO:1901318 | Negative regulation of flagellated sperm motility | Increases phenotype | PMID:29741722; PMID:31532523 |
| GO:1901670 | Negative regulation of superoxide dismutase activity | Increases phenotype | PMID:29199064 |
| GO:1901726 | Negative regulation of histone deacetylase activity | Increases phenotype | PMID:36534918 |
| GO:1901741 | Positive regulation of myoblast fusion | Increases phenotype | PMID:32750123 |
| GO:1901988 | Negative regulation of cell cycle phase transition | Increases phenotype | PMID:37717640 |
| GO:1902512 | Positive regulation of apoptotic dna fragmentation | Increases phenotype | PMID:35900689 |
| GO:1902552 | Negative regulation of catalase activity | Increases phenotype | PMID:37002642 |
| GO:1903047 | Mitotic cell cycle process | Affects phenotype | PMID:31601247; PMID:38211720 |
| GO:1903283 | Negative regulation of glutathione peroxidase activity | Increases phenotype | PMID:29199064; PMID:31875995 |
| GO:1903284 | Positive regulation of glutathione peroxidase activity | Decreases phenotype | PMID:28259788 |
| GO:1903353 | Regulation of nucleus organization | Affects phenotype | PMID:31750923 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Decreases phenotype | PMID:36565802 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:28259788; PMID:29940534; PMID:32023790; PMID:37944787; PMID:39059691 |
| GO:1903709 | Uterine gland development | Increases phenotype | PMID:27473340; PMID:37234927 |
| GO:1903787 | Negative regulation of glutathione biosynthetic process | Increases phenotype | PMID:35900689 |
| GO:1903966 | Monounsaturated fatty acid biosynthetic process | Affects phenotype | PMID:30145421 |
| GO:1904077 | Negative regulation of estrogen biosynthetic process | Increases phenotype | PMID:37944787 |
| GO:1904251 | Regulation of bile acid metabolic process | Affects phenotype | PMID:33078840 |
| GO:1904808 | Positive regulation of protein oxidation | Increases phenotype | PMID:35900689 |
| GO:1905517 | Macrophage migration | Increases phenotype | PMID:38908815 |
| GO:1990138 | Neuron projection extension | Decreases phenotype | PMID:31812737 |
| GO:2000035 | Regulation of stem cell division | Increases phenotype | PMID:36565802 |
| GO:2000184 | Positive regulation of progesterone biosynthetic process | Increases phenotype | PMID:25576683 |
| GO:2000225 | Negative regulation of testosterone biosynthetic process | Increases phenotype | PMID:29940534 |
| GO:2000278 | Regulation of dna biosynthetic process | Affects phenotype | PMID:31750923 |
| GO:2000355 | Negative regulation of ovarian follicle development | Increases phenotype | PMID:37002642 |
| GO:2000469 | Negative regulation of peroxidase activity | Increases phenotype | PMID:29940534 |
| GO:2000613 | Negative regulation of thyroid-stimulating hormone secretion | Increases phenotype | PMID:37002642 |
| GO:2000614 | Positive regulation of thyroid-stimulating hormone secretion | Increases phenotype | PMID:37487893 |
| GO:2000832 | Negative regulation of steroid hormone secretion | Increases phenotype | PMID:38966215 |
| GO:2000833 | Positive regulation of steroid hormone secretion | Increases phenotype | PMID:37717640 |
| GO:2000835 | Negative regulation of androgen secretion | Increases phenotype | PMID:38966215 |
| GO:2000844 | Negative regulation of testosterone secretion | Increases phenotype | PMID:29940534 |
| GO:2000845 | Positive regulation of testosterone secretion | Increases phenotype | PMID:30629253 |
| GO:2000859 | Negative regulation of aldosterone secretion | Increases phenotype | PMID:38966215 |
| GO:2000865 | Negative regulation of estradiol secretion | Increases phenotype | PMID:37002642 |
| GO:2000866 | Positive regulation of estradiol secretion | Increases phenotype | PMID:29741722; PMID:37717640 |
| GO:2000871 | Negative regulation of progesterone secretion | Increases phenotype | PMID:37002642; PMID:38966215 |
| GO:2000872 | Positive regulation of progesterone secretion | Increases phenotype | PMID:37717640 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.